BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Boehringer Ingelheim Partners With TARGET PharmaSolutions to Progress NASH Research

  TARGET PharmaSolutions is pleased to announce that Boehringer Ingelheim has entered into a multi-year strategic partnership for TARGET-NASH.

  October 19, 2017

   · 

  3 min read
• Business

  Cerveau Technologies Signs Research Agreement With Columbia University Medical Center

  Cerveau Technologies Inc. today announced an agreement with Columbia University Medical Center in New York, New York to support multiple projects over the next several years.

  October 19, 2017

   · 

  3 min read
• Business

  Median Technologies Appoints Vivian Wang As General Manager, China and Takashi Hayashi As Managing Director, Japan

  Median Technologies, The Imaging Phenomics Company today announces the appointment of Vivian Wang as General Manager, China and the appointment of Takashi Hayashi as Managing Director, Japan.

  October 19, 2017

   · 

  5 min read
• Biotech Bay

  Asterias Biotherapeutics Announces Closing of $10.4M Registered Direct Offering

  Asterias intends to use the net proceeds from this offering for clinical trial and process development activities related to its AST-OPC1 .

  October 19, 2017

   · 

  3 min read
• Business

  Clinical Genomics Working with Leading Cancer Center to Evaluate Colvera in Patients With Colorectal Cancer

  The new study will use Colvera to measure circulating tumor DNA (ctDNA) in rectal cancer patients.

  October 19, 2017

   · 

  2 min read
• Business

  AMAG Pharmaceuticals to Host Third Quarter 2017 Financial Results Conference Call and Webcast on Thursday, November 2, 2017 at 8:00 a.m. ET

  Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.

  October 19, 2017

   · 

  1 min read
• Drug Development

  Atara Biotherapeutics Initiates 60 Patient, Global Phase 1 Clinical Study to Evaluate Allogeneic ATA188 in Patients with Progressive or Relapsing-Remitting Multiple Sclerosis (MS)

  Enrollment to begin in Australia; U.S. sites expected to open in early 2018.

  October 19, 2017

   · 

  7 min read
• Drug Development

  Calithera Announces First Patient Treated in Phase I Cohort of INCB01158 Dosed in Combination With Keytruda

  The Phase 1 trial is designed to evaluate the safety and recommended Phase 2 dose of INCB01158 as a monotherapy, and in combination with immune checkpoint therapy.

  October 19, 2017

   · 

  4 min read
• Transgene: Third Quarter Marked by Progress in Clinical Development and Research

  Transgene, a biotech company that designs and develops viral-based immunotherapies, today announces its business update for the quarter ending September 30, 2017.

  October 19, 2017

   · 

  7 min read
• Business

  AMRA and BioTelemetry Research Raise the Standard for Medical Imaging in NASH/NAFLD Clinical Trials

  AMRA and BioTelemetry Research Announced today the formation of an exclusive alliance for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) clinical trials.

  October 19, 2017

   · 

  4 min read